Department of Radiology
Found 20 results
Filters: Author is Schöder, Heiko  [Clear All Filters]
2023
Kurtz K, Eibler L, Dacek MM, Carter LM, Veach DR, Lovibond S, Reynaud E, Qureshy S, McDevitt MR, Bourne C et al..  2023.  Engineering CAR-T cells for radiohapten capture in imaging and radioimmunotherapy applications.. Theranostics. 13(15):5469-5482.
Kratochwil C, Fendler WP, Eiber M, Hofman MS, Emmett L, Calais J, Osborne JR, Iravani A, Koo P, Lindenberg L et al..  2023.  Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT).. Eur J Nucl Med Mol Imaging. 50(9):2830-2845.
Fendler WP, Eiber M, Beheshti M, Bomanji J, Calais J, Ceci F, Cho SY, Fanti S, Giesel FL, Goffin K et al..  2023.  PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0.. Eur J Nucl Med Mol Imaging. 50(5):1466-1486.
2021
Nehmeh SA, Moussa MB, Lee N, Zanzonico P, Gönen M, Humm JL, Schöder H.  2021.  Comparison of FDG and FMISO uptakes and distributions in head and neck squamous cell cancer tumors.. EJNMMI Res. 11(1):38.
2020
Nehmeh SA, Fox JJ, Schwartz J, Ballangrud ÅM, Schöder H, Zhao Y, Strauss HW, Yu A, Gupta D, Powell SN et al..  2020.  A pilot study of N-ammonia cardiac PET imaging to assess subacute cardiotoxicity following adjuvant intensity-modulated radiotherapy for locally advanced breast cancer.. Clin Imaging. 68:283-290.
2018
Fox JJ, Gavane SC, Blanc-Autran E, Nehmeh S, Gönen M, Beattie B, Vargas HA, Schöder H, Humm JL, Fine SW et al..  2018.  Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer.. JAMA Oncol. 4(2):217-224.
2017
Schwartz J, Grkovski M, Rimner A, Schöder H, Zanzonico PB, Carlin SD, Staton KD, Humm JL, Nehmeh SA.  2017.  Pharmacokinetic Analysis of Dynamic F-Fluoromisonidazole PET Data in Non-Small Cell Lung Cancer.. J Nucl Med. 58(6):911-919.
2016
Grkovski M, Schwartz J, Gönen M, Schöder H, Lee NY, Carlin SD, Zanzonico PB, Humm JL, Nehmeh SA.  2016.  Feasibility of 18F-Fluoromisonidazole Kinetic Modeling in Head and Neck Cancer Using Shortened Acquisition Times.. J Nucl Med. 57(3):334-41.
Grkovski M, Schwartz J, Rimner A, Schöder H, Carlin SD, Zanzonico PB, Humm JL, Nehmeh SA.  2016.  Reproducibility of F-fluoromisonidazole intratumour distribution in non-small cell lung cancer.. EJNMMI Res. 6(1):79.
2013
E Ryan R, Sofocleous CT, Schöder H, Carrasquillo JA, Nehmeh S, Larson SM, Thornton R, Siegelbaum RH, Erinjeri JP, Solomon SB.  2013.  Split-dose technique for FDG PET/CT-guided percutaneous ablation: a method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness.. Radiology. 268(1):288-95.
2011
Fox JJ, Autran-Blanc E, Morris MJ, Gavane S, Nehmeh S, Van Nuffel A, Gönen M, Schöder H, Humm JL, Scher HI et al..  2011.  Practical approach for comparative analysis of multilesion molecular imaging using a semiautomated program for PET/CT.. J Nucl Med. 52(11):1727-32.
2009
Lee N, Nehmeh S, Schöder H, Fury M, Chan K, C Ling C, Humm J.  2009.  Prospective trial incorporating pre-/mid-treatment [18F]-misonidazole positron emission tomography for head-and-neck cancer patients undergoing concurrent chemoradiotherapy.. Int J Radiat Oncol Biol Phys. 75(1):101-8.
2008
Greco C, Nehmeh SA, Schöder H, Gönen M, Raphael B, Stambuk HE, Humm JL, Larson SM, Lee NY.  2008.  Evaluation of different methods of 18F-FDG-PET target volume delineation in the radiotherapy of head and neck cancer.. Am J Clin Oncol. 31(5):439-45.
Lee NY, Mechalakos JG, Nehmeh S, Lin Z, Squire OD, Cai S, Chan K, Zanzonico PB, Greco C, Ling CC et al..  2008.  Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study.. Int J Radiat Oncol Biol Phys. 70(1):2-13.
Lin Z, Mechalakos J, Nehmeh S, Schöder H, Lee N, Humm J, C Ling C.  2008.  The influence of changes in tumor hypoxia on dose-painting treatment plans based on 18F-FMISO positron emission tomography.. Int J Radiat Oncol Biol Phys. 70(4):1219-28.
2007
Meirelles GSP, Erdi YEmre, Nehmeh SA, Squire OD, Larson SM, Humm JL, Schöder H.  2007.  Deep-inspiration breath-hold PET/CT: clinical findings with a new technique for detection and characterization of thoracic lesions.. J Nucl Med. 48(5):712-9.
Nehmeh SA, Erdi YE, Meirelles GSP, Squire O, Larson SM, Humm JL, Schöder H.  2007.  Deep-inspiration breath-hold PET/CT of the thorax.. J Nucl Med. 48(1):22-6.
2004
Erdi YE, Nehmeh SA, Pan T, Pevsner A, Rosenzweig KE, Mageras G, Yorke ED, Schöder H, Hsiao W, Squire OD et al..  2004.  The CT motion quantitation of lung lesions and its impact on PET-measured SUVs.. J Nucl Med. 45(8):1287-92.
2003
Nehmeh SA, Erdi YE, Rosenzweig KE, Schöder H, Larson SM, Squire OD, Humm JL.  2003.  Reduction of respiratory motion artifacts in PET imaging of lung cancer by respiratory correlated dynamic PET: methodology and comparison with respiratory gated PET.. J Nucl Med. 44(10):1644-8.
2002
Nehmeh SA, Erdi YE, Ling CC, Rosenzweig KE, Schöder H, Larson SM, Macapinlac HA, Squire OD, Humm JL.  2002.  Effect of respiratory gating on quantifying PET images of lung cancer.. J Nucl Med. 43(7):876-81.